Elopag 50 mg (Eltrombopag) Complete Guide to Uses, Benefits, Dosage, Safety & Affordable Access
What Is Elopag 50 mg?
Elopag 50 mg is a prescription oral tablet that contains eltrombopag. It is a thrombopoietin receptor agonist used to raise low platelet counts. The reference brands are Promacta and Revolade. Elopag offers the same active ingredient as a high-quality generic option.
Patients searching for Elopag 50 mg need reliable help for low platelets caused by chronic immune thrombocytopenia (ITP), chronic hepatitis C, or severe aplastic anemia. Each tablet delivers 50 mg of Eltrombopag. Unit Pharmacy supplies it in a convenient 28-tablet pack.
This medicine stimulates the bone marrow to produce more platelets. Higher platelet counts help reduce the risk of bleeding. Many patients gain better control of their condition when the treatment is monitored carefully.
Manufacturer & Supplier Details
Everest Pharmaceuticals PLC, a Bangladesh-based company operating under cGMP compliance, manufactures Elopag 50 mg. The company follows strict quality standards that support consistent safety and efficacy.
Unit Pharmacy supplies genuine Elopag 50 mg. We ship to Saudi Arabia, the UAE, Qatar, Kuwait, Bahrain, Oman, Jordan, Lebanon, Syria, Yemen, Egypt, Turkey, Australia, and New Zealand. Delivery uses DHL Express and EMS with 5–20 day tracked service. A valid prescription is required. Prices are subject to change.
Pharmaceutical Formulation of Elopag 50 mg
Elopag 50 mg is a film-coated oral tablet.
Key details:
Active ingredient: Eltrombopag olamine equivalent to eltrombopag 50 mg
Dosage form: Oral film-coated tablet
Strength: 50 mg
Pack size: 28 tablets
Route: Oral use only
Manufacturer: Everest Pharmaceuticals PLC
The formulation is designed for reliable absorption when taken correctly. Proper timing with food and minerals is essential for full effect.
Mechanism of Action: How Elopag 50 mg Works
Elopag 50 mg belongs to the thrombopoietin receptor agonist (TPO-RA) class. Thrombopoietin is a natural protein that signals the bone marrow to make platelets.
Eltrombopag binds to the thrombopoietin receptor on bone marrow cells. This activates signaling pathways that increase the number and maturation of megakaryocytes. These large cells then produce more platelets.
Unlike treatments that only slow platelet destruction, Elopag works at the source by boosting production. The goal is not a normal platelet count but a level high enough to lower bleeding risk, usually above 50 × 10⁹/L.
Indications: When Is Elopag 50 mg Prescribed?
Doctors prescribe Elopag 50 mg for:
- Persistent or chronic immune thrombocytopenia (ITP) in adults and children (age 1 year and older) when other treatments such as corticosteroids or immunoglobulins have not worked well enough.
- Thrombocytopenia in patients with chronic hepatitis C virus infection so that interferon-based therapy can be started or continued.
- Severe aplastic anemia in patients who have had an insufficient response to immunosuppressive therapy.
Elopag is not indicated for myelodysplastic syndromes. Your doctor decides if it is appropriate after reviewing your platelet counts and overall health.
Who Should Use Elopag 50 mg?
Elopag 50 mg suits adults and eligible children with low platelets from chronic ITP, chronic hepatitis C, or refractory severe aplastic anemia who need an oral option to raise platelet production. It appeals to patients seeking a more affordable alternative to the originator brands.
It is not for everyone. Doctors check liver function, platelet history, and risk of blood clots before starting. Regular blood tests remain essential throughout treatment.
Dosage & Administration: How to Take Elopag Safely
The usual starting dose for most adults with ITP is elopag 50 mg once daily. Patients of East or Southeast Asian ancestry and those with mild to severe hepatic impairment usually start at 25 mg once daily.
For severe aplastic anemia the starting dose is often 50 mg once daily (or lower in special populations). The maximum dose for ITP is generally 75 mg daily. Dose adjustments depend on platelet response.
Critical rules for taking Elopag tablet:
- Take on an empty stomach — at least 1 hour before or 2 hours after a meal.
- Avoid dairy products, antacids, and supplements containing calcium, magnesium, iron, zinc, or aluminum for 4 hours before and 2 hours after the dose. These minerals can bind the medicine and reduce absorption dramatically.
- Swallow the tablet whole with water.
- Take it at the same time each day.
Your doctor will adjust the dose based on weekly platelet counts at the start of therapy. The aim is the lowest dose that keeps platelets high enough to reduce bleeding risk without going too high.
If you miss a dose, take the next dose at the regular time. Do not double the
Clinical Benefits & Evidence
Clinical trials support the benefits of eltrombopag. In the long-term EXTEND study for ITP, a high proportion of patients reached the target platelet count of ≥50 × 10⁹/L. Many maintained responses with continued treatment.
In severe aplastic anemia, combining eltrombopag with standard immunosuppressive therapy produced higher complete response rates than immunosuppression alone in key studies.
Benefits include:
- Increased platelet production that lowers bleeding risk
- Oral convenience compared with some injectable options
- Ability to support antiviral therapy in selected hepatitis C patients
- Durable responses for many patients under proper monitoring
- More affordable access through quality generics such as Elopag
Real-world use confirms that consistent dosing and lab monitoring help most patients achieve safer platelet levels.
Elopag 50 mg Side Effects
Common side effects include nausea, diarrhea, cough, headache, fatigue, fever, and elevated liver enzymes.
Other reported effects can include anemia, muscle or joint pain, and upper respiratory infections.
Serious risks include:
- Hepatotoxicity- liver enzyme elevations require regular monitoring and sometimes dose interruption
- Thrombotic or thromboembolic events (including portal vein thrombosis) if platelet counts rise too high
- Cataracts with long-term use (baseline and periodic eye exams are recommended)
- Potential for excessive platelet increase if dosing is not adjusted
Report yellowing of the skin or eyes, dark urine, severe abdominal pain, leg swelling, chest pain, or sudden shortness of breath immediately.
Precautions, Warnings & Contraindications
Continuous liver function monitoring is essential. Interrupt treatment if liver enzymes rise significantly and resume only under medical guidance.
Monitor platelet counts closely to avoid both bleeding risk and clot risk. Do not use Elopag to normalize platelet counts – the goal is a safe range.
Use caution in patients with known risk factors for blood clots or existing liver disease.
Drug Interactions
Polyvalent cations (calcium, iron, magnesium, zinc, aluminum) strongly reduce absorption. Follow the 4-hour separation rule strictly.
Eltrombopag can increase levels of certain statins (for example rosuvastatin). Dose reduction of the statin is often needed.
Other interactions may occur with CYP1A2 or CYP2C8 modulators. Always share your full medication and supplement list with your doctor and pharmacist.
Use in Pregnancy, Lactation & Special Populations
Eltrombopag may cause fetal harm. Effective contraception is recommended during treatment and for a short period afterward. Breastfeeding is generally not advised.
Dose reductions apply for East/Southeast Asian ancestry and hepatic impairment. Pediatric dosing starts lower in younger children. Geriatric patients may need closer monitoring.
Comparative Safety Profile vs Alternatives
Elopag (eltrombopag) belongs to the thrombopoietin receptor agonist family. Another common option is romiplostim (an injectable TPO-RA).
| Feature | Eltrombopag (Elopag) | Romiplostim | Supportive care only |
|---|---|---|---|
| How taken | Oral tablet once daily | Weekly injection | Varies |
| Main action | Stimulates platelet production | Stimulates platelet production | Supportive |
| Key monitoring | Platelets + liver enzymes | Platelets | Clinical |
| Common concerns | Hepatotoxicity, clots if high platelets | Injection site reactions, clots | Bleeding risk |
| Convenience | High (oral) | Lower (injection) | Variable |
| Generic availability | Yes (Elopag) | Limited | N/A |
Both TPO-RAs raise platelets effectively. Choice depends on patient preference, liver status, and prior response.
Elopag 50 mg Price, Cost & Online Buying Guide
Elopag 50 mg price is substantially lower than originator brands. Patients compare elopag 50 price, elopag tablet price, and elopag 50 mg price to find sustainable long-term options.
Unit Pharmacy offers competitive pricing for the genuine 28-tablet pack. Insurance coverage varies by country and plan. Some patients receive partial support. Always confirm current pricing.
How to Buy Elopag 50 mg Online
- Visit the Unit Pharmacy or Emergency Drug website.
- Search for Eopag 50 mg or Elopag tablet.
- Select the 28-tablet pack.
- Upload a valid prescription.
- Complete secure payment.
Why choose this pathway for buy Elopag 50 mg online: authentic product from Everest Pharmaceuticals PLC under cGMP standards, pharmacist support, tracked delivery, and focus on patient access. Prescription verification protects safety. Prices subject to change.
Storage Instructions
Store Elopag 50 mg tablets below 25°C in a cool, dry place. Protect from moisture and light. Keep out of reach of children and pets. Do not use it after the expiration date.
Patient Tips & When to Call a Doctor
Take the tablet exactly as directed on an empty stomach and follow the mineral separation rule every day. Attend all scheduled blood tests. Keep a simple log of doses and any bleeding or bruising.
Call your doctor right away for: yellowing of skin or eyes, dark urine, unusual fatigue, severe abdominal pain, leg swelling or pain, chest pain, sudden shortness of breath, or any new or worsening bleeding.
Conclusion
Elopag 50 mg provides an effective oral option for raising platelet counts in chronic ITP, hepatitis C-related thrombocytopenia, and severe aplastic anemia. Manufactured by Everest Pharmaceuticals PLC under cGMP standards and supplied by Unit Pharmacy, it combines clinical reliability with greater affordability and international access.
Proper medical supervision, strict dosing timing, and regular blood tests are essential for safe use. If you and your doctor determine this medicine is appropriate, Unit Pharmacy offers a straightforward path to genuine product with tracked shipping to supported destinations.
Visit the Unit Pharmacy website today to check current availability and pricing for Elopag 50 mg, upload your prescription, and place your order. Take the next step toward better platelet control with a trusted generic option. Always follow your healthcare provider’s guidance.
Unique FAQ Section
1.What is Elopag 50 mg used for?
Ans: Elopag 50 mg treats low platelet counts caused by chronic immune thrombocytopenia (ITP), chronic hepatitis C infection, and severe aplastic anemia. It stimulates the bone marrow to make more platelets.
- How much does Elopag 50 mg cost?
Ans: Generic pricing is significantly lower than originator brands. Check the current Elopag 50 mg price with your supplier for the latest 28-tablet pack cost.
- Can I buy Elopag 50 mg online?
Ans: Yes. Licensed suppliers such as Unit Pharmacy require a prescription and ship to many countries including Saudi Arabia, the UAE, Qatar, Kuwait, and others.
- What are the most important rules when taking Eltrombopag?
Ans: Take it on an empty stomach and keep a 4-hour gap from dairy products, antacids, and mineral supplements containing calcium, iron, magnesium, or zinc.
- Is Elopag the same as Promacta?
Ans: Elopag contains the same active ingredient (Eltrombopag) as Promacta/Revolade and is manufactured to quality standards as a generic alternative.
Medical Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Eltrombopag carries important safety warnings including hepatotoxicity and thrombosis risk. Use only under the direction of a qualified healthcare professional. Data are drawn from manufacturer information, regulatory labels (FDA/EMA), and published clinical studies.





Reviews
There are no reviews yet.